Literature DB >> 20392970

A long-term, prospective, randomized study comparing biodegradable and metal interference screws in anterior cruciate ligament reconstruction surgery: radiographic results and clinical outcome.

Sven Stener1, Lars Ejerhed, Ninni Sernert, Gauti Laxdal, Lars Rostgård-Christensen, Jüri Kartus.   

Abstract

BACKGROUND: During the past decade, the use of biodegradable implants in anterior cruciate ligament surgery has increased. HYPOTHESIS: Poly-L-lactide acid (PLLA) interference screws would render the same clinical results but greater tunnel enlargement than metal screws 8 years after anterior cruciate ligament reconstruction using hamstring tendon (semitendinosus/gracilis) autografts. STUDY
DESIGN: Randomized controlled trial; Level of evidence, 1.
METHODS: A randomized series of 77 patients, all with a unilateral anterior cruciate ligament rupture, were divided into 2 groups (PLLA and metal). In both groups, hamstring tendon autografts were used with interference screw fixation at both ends and the patients were examined with standard radiographs, Tegner activity level, Lysholm knee score, single-legged hop test, early C-reactive protein response, and KT-1000 arthrometer knee laxity measurements.
RESULTS: The preoperative assessments in both groups were similar in terms of gender, clinical tests, and the time from injury to surgery. The patients returned for a radiographic and clinical examination a mean of 96 months (range, 78-120 months) after the index operation. The PLLA group displayed significantly larger bone tunnels on the radiographs than the metal group on the femoral side (mean, 11.4 mm [range, 0-17.8 mm] vs 8.0 mm [range, 0-16.3 mm]; P < .005) but not on the tibial side (mean, 10.7 mm [range, 7.8-14.1 mm] vs 10.5 mm [range, 0-20.3 mm]; difference not significant). At follow-up, no significant differences were found between the PLLA and metal groups in terms of knee laxity measurements (median, 1.0 mm [range, -2.0-4.0 mm] vs 1.0 mm [range, -3.0-6.5 mm]), Tegner activity level (median, 7 [range,3-9] vs 6 [range, 2-9]), or the Lysholm knee score (median, 90 points [range, 51-100] vs 89 points [range, 53-100]). The C-reactive protein values did not differ significantly between the 2 groups except for an increase in the PLLA group compared with the metal group at day 1 postoperatively-23 mg/L (range, <6-55) vs 9 mg/L (range, <6-55) (P < .001).
CONCLUSION: There were significantly larger radiographically visible bone tunnels on the femoral side but not on the tibial side in the PLLA group compared with the metal group 8 years after anterior cruciate ligament reconstruction using hamstring tendon autografts. This finding did not correlate with inferior clinical results. Because of the results in the present study, the authors have discontinued the use of PLLA interference screws.

Entities:  

Mesh:

Year:  2010        PMID: 20392970     DOI: 10.1177/0363546510361952

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  24 in total

Review 1.  Pivot shift as an outcome measure for ACL reconstruction: a systematic review.

Authors:  Olufemi R Ayeni; Manraj Chahal; Michael N Tran; Sheila Sprague
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-01-05       Impact factor: 4.342

2.  Femoral tunnel enlargement after anterior cruciate ligament reconstruction using RigidFix compared with extracortical fixation.

Authors:  Osmar Valadao Lopes; Leandro de Freitas Spinelli; Luiz Henrique Cunha Leite; Bruce Quatrin Buzzeto; Paulo Renato Fernades Saggin; André Kuhn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-27       Impact factor: 4.342

3.  MRI-based tendon bone healing is related to the clinical functional scores at the first year after anterior cruciate ligament reconstruction with hamstring tendon autograft.

Authors:  Hong-Yun Li; Hong Li; Zi-Ying Wu; Ji-Wu Chen; Shi-Yi Chen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-05-15       Impact factor: 4.342

4.  Meta-analysis comparing bioabsorbable versus metal interference screw for adverse and clinical outcomes in anterior cruciate ligament reconstruction.

Authors:  Pat Laupattarakasem; Malinee Laopaiboon; Weerachai Kosuwon; Wiroon Laupattarakasem
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-12-14       Impact factor: 4.342

Review 5.  Fixation techniques for the anterior cruciate ligament reconstruction: early follow-up. A systematic review of level I and II therapeutic studies.

Authors:  Andrea Speziali; Marco Delcogliano; Matteo Tei; Giacomo Placella; Matteo Bartoli; Amerigo Menghi; Giuliano Cerulli
Journal:  Musculoskelet Surg       Date:  2014-10-01

6.  Comparison of resorption and remodeling of bioabsorbable interference screws in anterior cruciate ligament reconstruction.

Authors:  Panagiotis G Ntagiopoulos; Guillaume Demey; Thierry Tavernier; David Dejour
Journal:  Int Orthop       Date:  2014-09-18       Impact factor: 3.075

7.  Painful knee joint after ACL reconstruction using biodegradable interference screws- SPECT/CT a valuable diagnostic tool? A case report.

Authors:  Michael T Hirschmann; Tom Adler; Helmut Rasch; Rolf W Hügli; Niklaus F Friederich; Markus P Arnold
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-09-16

Review 8.  Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction.

Authors:  Pedro Debieux; Carlos E S Franciozi; Mário Lenza; Marcel Jun Tamaoki; Robert A Magnussen; Flávio Faloppa; João Carlos Belloti
Journal:  Cochrane Database Syst Rev       Date:  2016-07-24

Review 9.  Current trends in anterior cruciate ligament reconstruction.

Authors:  Ha Sung Kim; Jong Keun Seon; Ah Reum Jo
Journal:  Knee Surg Relat Res       Date:  2013-11-29

10.  Comparison of tendon-bone healing between autografts and allografts after anterior cruciate ligament reconstruction using magnetic resonance imaging.

Authors:  Yunshen Ge; Hong Li; Hongyue Tao; Yinghui Hua; Jiwu Chen; Shiyi Chen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-07       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.